The study was conducted to assess the impact of two doses of coenzyme Q10 on seminal fluid parameters and antioxidant status in infertile men.

The aim of this study was to assess the impact of two doses of coenzyme Q10 on seminal fluid parameters and antioxidant status in infertile men with idiopathic oligoasthenoteratospermia.

Inclusion Criteria:

• History of infertility of at least 12 months despite regular unprotected intercourse.

Oligoasthenoteratospermia was diagnosed by semen analysis showing abnormal sperm concentration (<15 million/ml), progressive motility (<32%), total motility (<40%) and morphology (<30% WHO criteria) as defined by WHO manual for semen analysis 2010

Exclusion Criteria:

• Azoospermia,
• Varicocele,
• Genital tract infection,
• Cryptorchidism,
• Testicular trauma or scrotal surgery,
• Endocrine disorder,
• Systemic illness,
• Smoking
• The presence of female factor

Male Infertility

Patients data are anonymous and in hold with the principal investigator

Open Label